Iowaclinic.com
March 2010 Reading Time: 15 Minutes
• Essure – A n Office-based
le5950 Univading
ersity Avenue West Des Moines 50266
515.875.9 dge
Permanent Birth Control
2 Option for Your Patients
3 Hearing Technology
• Research News in Brief
100 iowaclinic.com
innovation communication education
Laparoscopy for Gynecologic Cancers
The Access Center at The Iowa Clinic
By Steven Elg, M.D., Ph.D. – Gynecologic Oncologist
By John Matsuura, MD – Vascular Surgeon
The Iowa Clinic Gynecologic Oncology Department
The Iowa Clinic Cardiovascular Services Department
The Iowa Clinic's Gynecologic Oncology Department
A patient who faces the prospect of hemodialysis for
is pleased to offer the only Single Port Laparoscopic
renal failure has tremendous challenges that will alter
Program in Iowa for suspected pelvic masses,
his or her lifestyle forever. They must commit a half
prophylactic salpingo-oophorectomies for patients with
day to treatment an average of three times a week.
BRCA1/2 mutations as well as early endometrial cancers.
Unfortunately, the hemodialysis access fistulas and catheters are prone
to complications of thrombosis and infection. It takes a dedicated staff
The idea behind this innovative approach is to utilize a single small
to monitor and maintain dialysis access in these patients. As vascular
incision in a natural orifice of the body such as the umbilicus. Unlike
surgeons, we have often played a role in creating
robotic surgery which leaves the patient with four to five incisions up to
hemodialysis access fistulas and grafts.
¾ of an inch in size or traditional laparoscopy which results in three to
However, the role of maintenance was
four ½ inch incisions, single port laparoscopic surgery employs a single ¾
not clearly defined and patients often
inch incision that is virtually "scar less".
presented when their access had
already failed. Nephrologists and
Since performing the first single port hysterectomy in Central Iowa last
dialysis centers had few options
year we have found that patient satisfaction has been extraordinarily
beyond sending patients to
favorable. Technological advances that make the surgery possible include
radiology, where they sat in a
a 5 mm laparoscope with an articulating head and exceptionally good
crowded waiting room until their
optics as well as articulating 5mm instruments. Sometimes multiple
name was called to undergo
complex procedures can be performed through the same small single
treatment of their failed access.
incision by a team of trained surgeons. Recently Dr. Fialkov, a Urologist
with The Iowa Clinic, performed a partial nephrectomy and I followed
As a group, we recognized the
to remove bilateral ovarian masses through the same tiny incision. This
growing problem. How would we
surgery was reported to be the first of its kind in Iowa and resulted in a
feel, if we were in their situation? Is
very short hospitalization as well as a minimal scar for the patient.
there a more efficient and cost effective
solution? Two months ago, we opened
Single port laparoscopy may not be suitable for all women requiring
the doors to the Access Center at The Iowa
surgery for a gynecologic malignancy, which is why we also perform
Clinic. It is the first access center in Iowa and is designed with a clinic
robotic and traditional laparoscopy. A decision on the surgical
approach to the problem of hemodialysis access. Jessica is our dedicated,
approach should be made
full time receptionist and scheduling secretary. She talks directly with
after careful consultation
the dialysis centers and schedules the patients for appointments rather
with a physician familiar
than the traditional, come early and "pick a number and wait in line".
with all available techniques.
Barb Thompson is our access nurse who has many years of experience
in both critical care and radiology nursing. Stephanie Steuben is our
To contact Dr. Elg please
certified radiology technician who comes with several years of experience
call 515-241-4161.
in endovascular therapy. Our vascular group covers the Access Center
full time to meet the needs of our patients. It is hoped, the patients
will recognize our center as their doctor's office. No more hospital
registration and sitting in crowded waiting areas. The came walk in
and have immediate service. We are also providing ongoing monitoring
of their access. We place a high priority on education. Through word
of mouth from our patients, we now see referrals from over 15 dialysis
centers in the State of Iowa from places as far away as Ottumwa and
continued on next page >
®2010 The Iowa Clinic, P.C.
Essure – An Office-based Permanent Birth Control Option for Your Patients
By Steven Keller, M.D. – Obstetrician & Gynecologist
The Iowa Clinic Obstetrics & Gynecology Department
The patient typically is instructed to take an over the counter NSAID,
such as Ibuprofen, prior to arriving. Consent is obtained and a negative
pregnancy test verified. Toradol IM and a paracervical block are
Permanent contraception for women via a simple office
administered for patient comfort and to reduce the chance of tubal
procedure has been available through our office for
spasm. A small 5.5 mm hysteroscope with saline is introduced into the
nearly 3 years and has become the method of choice
uterus, typically with no dilation required. Once both internal ostia are
for most women seeking permanent, non-hormonal birth control.
identified, the micro-inserts are placed under direct visualization. The
The Essure micro-insert tubal occlusive devise allows the patient to
patient is also able to watch the procedure herself as the micro-inserts
obtain permanent sterilization in the office setting without the need for
are placed. She is observed shortly following the procedure, and then
general anesthesia and with no incisions. Compared to the traditional
discharged to home. She may resume normal activities immediately if
laparoscopic tubal ligation, this procedure offers a much quicker recovery, desired. The entire procedure takes 35 minutes on average.
less risk of operative or anesthetic complications and is considerably less
expensive. Some patients will pay only the cost of a simple office co-pay.
Like many procedures, the devise was initially placed in an outpatient
Patients may experience some mild cramping or spotting for 24 – 48
surgical setting when first introduced in 2002, but has quickly become
hours, but symptoms typically respond well to Ibuprofen and rest if
a popular office procedure. Since FDA approval, tens of thousands of
needed. She should continue to use an alternative birth control method
women worldwide have had the procedure and studies confirm 99.8%
until the HSG is performed 3 months later.
effectiveness at 4 years follow-up.
Patient Selection
The Essure procedure is a minimally invasive, non-incisional office
First and foremost, this procedure is considered to be 100% permanent
procedure which can provide permanent birth control with less risk,
and not to be considered reversible. Since there are no hormones
less discomfort, quicker recovery, greater efficacy and less cost than
involved, the procedure will have no effect on cycle length, flow,
laparoscopic tubal ligation, and may even be an option for some patients
premenstrual symptoms or menopause. Patients should therefore be
that would not be laparoscopic tubal ligation candidates.
counseled that their menses will likely return to "normal" but should
be reminded that this may be heavier than expected if recently on
If and when you have a patient who is a candidate for Essure, we hope you'll
oral contraceptives.
consider The Iowa Clinic Obstetrics & Gynecology Department. Call 875-9290.
The ideal office candidate should demonstrate normal pelvic anatomy
The Essure® Procedure for Permanent Birth Control
e Esssssuu
uree® Procedure for Permanent Birth Contro
and be able to tolerate up to 30 minutes in dorsal lithotomy position.
This can be assessed at the pre-operative consultation visit.
The Essure® Procedure for Permanent Birth Control
The Essure micro-inserts are inserted through the vagina
There are very few contraindications but the procedure should not be
The Essure micro-inserts are inserted through the vagina
nd i ssnnssttuurr
e Fcicaa rrllEssur
t inn tshccrhriiss iiar
and into the Fal opian tubes without incisions.
performed in individuals with a known nickel hypersensitivity, known
and into the Fal opian tubes without incisions.
the vagina and into the Fallopian tubes
allergy to contrast media, active pelvic infection or any pregnancy event
without incisions.
within the last 6 weeks.
This procedure can also be performed in situations in which laparoscopic
e EEssssuurree m
miiccrroo--iinnse
placement,icr roo
tubal ligation would not typically be advised such as severe pelvic
Fww lalhhooiipipain t
e m cicrroo--inise
e bararrrieier fo
to fit each Fallopian
tube. This helps to hold the
adhesive disease or multiple prior abdominal/pelvic surgeries. Those
micro-inserts in place while a tissue barrier forms.
with cardiovascular or respiratory conditions that may make general
anesthesia undesirable may also be candidates for the Essure in an
office setting.
g thh During the 3 months af
e EEssssuurree p
prrter the Essur
oocceedduurree, t
into the Essure micro-inserts to form a natural, permanent barrier.
he hEe 3 m
e Essssuurree mi
m cicrroo--inise
nt bararrrieier.r.
tissue grows into the Essure micro-inserts to form a
Mechanism of Action
natural, permanent barrier.
The small, flexible micro-inserts consist of polyethylene fibers tightly
wrapped around a stainless steel inner core. An expandable nickel
alloy coil surrounds the device and when deployed anchors the device
TThhee EEssssuurree C
Confir eerrffoorrmmee
or med after 3 months. Dye
within the junction of the uterus and fallopian tube. Once placed,
ssuurr o c
is inserted into the uterus and an x-ray is taken to confirm that
the polyethylene fibers cause reactive in-growth of tissue, which both
n Essssuurree
the tubes are blocked and that reliance on Essure for permanent
permanently blocks the tubes and permanently holds the device in
birth control can begin.
place. This process is generally completed in 3 months and a follow-up
low-pressure office radiographic hysterosalpingogram (HSG) is performed
to confirm tubal occlusion. Occasionally, an additional 3 months may be
Copyright 2007 Conceptus Incorporated. All Right
s Reserved. CC-0304 09Nov07F
Copyright 2007 Conceptus Incorporated. All Rights Reserved. CC-0304 09Nov07F
Copyright 2007 Conceptus Incorporated. All Rights Reserved. CC-0304 09Nov07F
Copyright 2007 Conceptus Incorporated. All Rights Reserved. CC-0304 09Nov07F
required for complete occlusion.
The Access Center. . continued from previous page
Renal failure will continue to become a major health care problem with
amounts to six times the value of all the gold in Fort Knox. It is our hope,
an average growth rate of 7% per year. In the U.S. alone, this is a 75
that the Access Center at the Iowa Clinic will become recognized as a
billion dollar problem. World wide, there are over 2 million patients
quality leader in this area.
on chronic hemodialysis and it is estimated that the cost of dialysis will
reach one trillion dollars in the next decade. To put it in perspective, that The Iowa Clinic Vascular Access Center can be reached at 515-875-9750.
Advances in Hearing Technology
research news in Brief The Iowa Clinic Department of Urology has a long history of providing
By Jennifer Brown, MA, CCC-A – Audiologist
the finest care for patients in Central Iowa. The department has
The Iowa Clinic Audiology & Hearing Aid Department
participated in clinical research for over 13 years, including phase II
through phase IV studies, as well as device studies. They have worked
Hearing aids have come a long way since our
with most major pharmaceutical companies and sponsors. Conducting
grandparents' times. Gone are the days of the clunky,
clinical research allows the specialty physicians access to leading edge
cumbersome, whistling monstrosity jutting out of the ears medicine and treatment, and provides patients with the most current
of those with hearing impairment. Today's hearing aids
aspects of medical science.
are more sleek and streamlined than ever. Not only have the cosmetic
aspects of hearing instruments been greatly enhanced, the internal
Studies have been completed in nearly every urologic condition,
features and fidelity of these new instruments has skyrocketed over
including BPH, prostate cancer, erectile dysfunction, bladder cancer,
the past 5 years.
overactive bladder, stress urinary incontinence, prostatitis, and
hypogonadism. The research department has been a research center
According to the
for pivotal new drug applications to the FDA for the following
Sergi Kochin, Ph.D.,
medications, Cialis, Avodart, Uroxatral, Enablex, Vesciare, Toviaz
and Zometa to name a few.
Hearing Institute,
Right now a multi-center study is underway using High Intensity
people in America
Focused Ultrasound (HIFU) for prostate cancer. It gives the patient
have hearing loss,
an opportunity to undergo therapy that offers minimally invasive
while there are 22
treatment for recurrent localized prostate cancer that has not spread
million people in
or metastasized outside the prostate. It is considered investigational in
the United States and The Iowa Clinic is one of 20 centers undergoing
never tried hearing
clinical trials for FDA approval. (HIFU is already approved and used
aids. We hope to
outside the US. Precision focused ultrasound waves are used to ablate
diseased prostate tissue via the Sonablate 500 system. The treatment can
be repeated if necessary, and having HIFU does not preclude patients
With these advancements in technology we are now able to help patients
from having further treatment).
that we might not have been able to help in the recent past. Not only
has the criteria for hearing aid candidacy been expanded, but the new
Urologists at TIC have also begun an international multi-center clinical
range of features within the instruments themselves allow exceptional
trial to explore treatment for patients with overactive bladder symptoms
customization to fit the even the most outgoing lifestyles our
that could offer improvement over traditional drug therapy. Patients
that are refractive to medical therapy are invited to participate in a
double blind, randomized, placebo-controlled study using Botox
Active learning processes within the hearing instruments analyze the
(Botulinum Toxin Type A) for patients with Idiopathic OAB with
wearers preferences in actual listening environments and customize
urinary incontinence.
the settings accordingly. The need for manual adjustments is ultimately
reduced, as is the need for numerous return appointments for the
For more information about the clinical research conducted at TIC or about the
audiologist to adjust the hearing aid. After all, who is more capable
above studies, please contact the research nurses at 515-875-9815, you can also
of making decisions regarding their own listening preferences than
reach Mary Lepic at [email protected].
the patients themselves?
You can contact the Urology Department directly to speak to one of the
The most exciting advancement in recent years has been connectivity.
participating urologists at 515-875-9800.
Hearing aids can now be synched wirelessly to cell phones, televisions,
MP3 players and computers. This allows the patient to listen to these
devices directly through the prescription tuned hearing instruments,
providing exceptional signal-to-noise ratios and clarity. The hearing
aid wearer simply carries a small, discreet interface that links the hearing
instrument to a number of selected devices and transmits the sound
wirelessly to the ear.
Amerlon Enriquez, M.D., is now board certified in sleep
medicine. Dr. Enriquez is the second board certified sleep
In a nutshell…out with the old and in with the new. Hearing aids have
specialist at The Iowa Clinic and the West Lakes Sleep Center.
indeed come a long way. We are excited to offer this new technology to
customize prescription tuned hearing instruments to the high-tech,
active lifestyles with which our patients have challenged us.
Amy McEntaffer, M.D., is now board certified in
The Iowa Clinic Audiology/Hearing Technology Department is supported by
Obstetrics & Gynecology.
five board certified otolaryngologists. Please call 515-875-9450 to schedule
John Houghton, D.O., is now board certified in
Obstetrics & Gynecology.
TE OFFICE 515-875-9100 WEST LAKES CAMPUS 515-875-9000
OBSTETRICS
SURGICAL OnCOLOGY
Richard B. Merrick, MD
P. Sue Beckwith, MD
Vimala V. Chandran, MD
& GYnECOLOGY
Daniel R. Kollmorgen, MD
Richard J. Rinehart, MD
5950 University Ave., #135, WDM
Kevin J. Cunningham, MD
Robert J. Casper, MD
1212 Pleasant St., #211, DM
p: 875-9795 f: 875-9796
Jeffrey D. DeFrancisco, MD
Eric G. Garner, MD
p: 283-1541 f: 283-0473
5950 University Ave., #265, WDM
Charles O. Lozier, MD
John D. Houghton, DO
p: 875-9450 f: 875-9457
P. Sue Beckwith, MD
Thomas P. Luft, DO
Steven A. Keller, MD
TRAUMA SURGERY &
Michael J. Page, MD
Christina L. H. Taylor, MD
Amy B. McEntaffer, MD
SURGICAL CRITICAL CARE
AUDIOLOGY/
Kyle E. Rogers, MD
Rick L. Wilkens, MD
William H. Newland, MD
Sheryl M. Sahr, MD
1212 Pleasant St., #211, DM
M. Michelle Masterson, ARNP
A. Perry Osborn, DO
Richard A. Sidwell, MD
Dawn A. Baldwin, AuD, CCC-A
p: 283-1541 f: 283-0473
5950 University Ave., #151, WDM
Grant L. Paulsen, MD
James R. Swegle, MD
Jennifer L. Brown, MA, CCC-A
p: 875-9192 f: 875-9193
Gregg B. Polzin, MD
Peter M. Tonui, MD
Kimberly A. Krambeck, MA, CCC-A
Michael J. Page, MD
Stephanie Powell Morgan, MD
1212 Pleasant St., #211, DM
Sheryl D. Neal, AuD, CCC-A
411 Laurel St., #2380, DM
Sean D. Cunningham, MD
Robert S. Sieman, DO
p: 283-1541 f: 283-0473
5950 University Ave., #265, WDM
p: 288-5858 f: 288-5890
Richard B. Gloor, MD
Therese H. Tran, DO
p: 875-9450 f: 875-9457
Erin K. Herndon, MD
Jodi L. Aldrich, ARNP
Kyle E. Rogers, MD
Lisa J. Jensen, MD
Shawna M. Freeman, ARNP
Markham J. Anderson, MD
1212 Pleasant St., #410, DM
1301 Penn Ave., #115, DM
Nicole L. Meyer, PA-C
John C. Bardole, MD
p: 875-9450 f: 875-9457
p: 262-3143 f: 266-5116
Ralph R. Pray, MD
Melissa J. Phillips, ARNP
Jonathan M. Fialkov, MD
Louis E. Schneider, DO
5950 University Ave., #205, WDM
Brian L. Gallagher, MD
Julie A. Lehmann, ARNP
p: 875-9290 f: 875-9291
Richard L. Glowacki, MD
J. William Holtze, MD
Shelley M. Schossow, ARNP
Mark A. Kellerman, MD
Jonathan L. Fudge, MD
1221 Pleasant St., #500, DM
1215 Pleasant St., #206, DM
1221 Pleasant St., #400, DM
Michael W. Kent, MD
Frank N. Haugland, MD, PhD
p: 241-8660 f: 241-8662
p: 241-5743 f: 241-6474
p: 241-4161 f: 241-4162
Carl A. Meyer, MD
David K. Lemon, MD
Stephanie L. Pothoven, DO
James P. Lovell, DO
EAR, nOSE & THROAT
Todd C. Jensen, MD
1810 SW White Birch Circle, #111,
Harlan K. Rosenberg, MD
Mohamed A. Morsy, MD
Steven R. Herwig, DO, MBA
1223 Center St., #17, DM
Steven J. Rosenberg, MD
Pamela L. Nerheim, MD
Richard B. Merrick, MD
p: 282-0441 f: 282-0987
p: 875-9290 f: 875-9291
Ryan T. Schulte, MD
Dirk A. Ver Steeg, MD
Richard J. Rinehart, MD
Joseph M. Sawhill, ARNP
Douglas L. Schulte, MD
Kathleen R. Gannon, DO
Kathleen M. Massop, MD
Sheila A. Whyte, ARNP
Steven L. Loveland, ARNP
1810 SW White Birch Circle, #111,
1221 Pleasant St., #400, DM
5950 University Ave., #341, WDM
Cynthia G. Marske, ARNP
5950 University Ave., #265, WDM
p: 241-4161 f: 241-4162
p: 875-9800 f: 875-9802
5950 University Ave., #231, WDM
p: 875-9450 f: 875-9457
p: 964-7115 f: 964-7899
p: 875-9090 f: 875-9312
vASCULAR ACCESS CEnTER
1212 Pleasant St., #410, DM
Des Moines
5950 University Ave., #195, WDM
1215 Pleasant St., #618, DM
p: 875-9450 f: 875-9457
5950 University Ave., #150, WDM
p: 875-9750 f: 875-9751
p: 875-9090 f: 875-9312
p: 875-9500 f: 875-9696
Nicholas Honkamp, MD
vEIn THERAPY CEnTER
1810 SW White Birch Circle, #111,
Gloria J. Dayton, RN, BS
1215 Pleasant St., #408, DM
5950 University Ave., #175, WDM
5950 University Ave., #231, WDM
5950 University Ave., #180, WDM
p: 875-9500 f: 241-8985
p: 875-9908 f: 875-9909
p: 875-9090 f: 875-9077
p: 875-9090 f: 875-9312
p: 875-9145 f: 875-9146
ORTHOTICS & PROSTHETICS
WEST LAKES
1005 Pennsylvania Ave.,
FOOT & AnKLE
John D. Berger, MD
Mark A. McDonald, CPO
Christopher J. Ellerbroek, MD
12655 University Ave., #160, Clive
5950 University Ave., #141, WDM
Eric A. Barp, DPM
p: 875-9425 f: 875-9426
p: 875-9900 f: 875-9899
K. Linda Bratkiewicz, DPM
Gary L. Haynes, DO
David L. Groen, DPM
Rodion Herrera, DO
WEST LAKES SLEEP CEnTER
A. Nasser Khan, MD
5950 University Ave., #160, WDM
Kevin J. Koch, MD
Thomas D. Hansen, MD
5950 University Ave., #121, WDM
1215 Pleasant St., #618, DM
p: 875-9876 f: 875-9877
Daniel J. Krejchi, MD
5950 University Ave., #280, WDM
p: 875-9555 f: 875-9556
p: 875-9090 f: 241-8395
Susan B. Maurer, MD
p: 875-9902 f: 875-9903
5950 University Ave., #145, WDM
1005 Pennsylvania Ave., #102-A,
Laura L. Dakovich, DO
p: 244-5109 f: 875-9676
5950 University Ave., #150, WDM
Joy E. Trueblood, MD
p: 875-9500 f: 875-9501
John D. Hines, DO
1215 Pleasant St., #210, DM
5950 University Ave., #161,WDM
Charles C. Larson, MD
p: 244-5109 f: 241-4275
PHYSICAL MEDICInE
James G. Piros, MD
1215 Pleasant St., #408, DM
Ronald K. Grooters, MD
Ramon S. Reyes, MD
p: 244-5109 f: 241-8985
Todd C. Troll, MD
Robert F. Schneider, MD
Justin C. Rice, MD
5950 University Ave., #160, WDM
Kent C. Thieman, MD
Raneen E. Schulte, PA-C
1221 Pleasant St., #150, DM
p: 875-9885 f: 875-9886
1215 Pleasant St., #618, DM
5950 University Ave., #221, WDM
p: 244-5109 f: 241-3505
p: 875-9090 f: 241-5930
p: 875-9115 f: 875-9117
Kelly M. Brown, MPT
Anna M. DeWaay, MSPT
Dennis M. Fry, MD
Michael P. Mohan, MD
Douglas W. Brenton, MD
William A. Fellows, PT
Douglas W. Massop, MD
Frederick S. Nuss, MD
5950 University Ave., #171, WDM
Katherine K. Hippler, OTR/L
John H. Matsuura, MD
5950 University Ave., #135, WDM
p: 875-9250 f: 875-9251
5950 University Ave., #285, WDM
Eric C. Scott, MD
p: 875-9795 f: 875-9796
p: 875-9706 f: 875-9707
John A. Stern, MD
nEUROLOGICAL &
Anson A. Yeager, MD
Gerald G. Baker, MD
5950 University Ave., #231, WDM
Scott D. Hamling, MD
David J. Boarini, MD
Konstantinos P. Lekkas, MD
p: 875-9090 f: 875-9077
1212 Pleasant St., #211, DM
Thomas A. Carlstrom, MD
Mark A. Reece, MD
p: 283-1541 f: 283-0473
Robert G. Kerr, MD, PhD
Timothy M. Schurman, MD
Dennis M. Fry, MD
John G. Piper, MD
Lester J. Yen, MD
Douglas W. Massop, MD
GYnECOLOGIC
Jessica A. Benes, PA-C
5950 University Ave., #120, WDM
John H. Matsuura, MD
1215 Pleasant St., #608, DM
p: 875-9744 f: 875-9765
Eric C. Scott, MD
Steven A. Elg, MD, PhD
p: 241-5760 f: 241-8161
Anson A. Yeager, MD
1221 Pleasant St., #400, DM
PULMOnOLOGY, CRITICAL CARE
1215 Pleasant St., #618, DM
p: 241-4161 f: 241-4162
& SLEEP MEDICInE
p: 875-9090 f: 875-9077
John D. Berger, MD
Angela S. Collins, MD
HAnD SURGERY
1221 Pleasant St., #150, DM
Amerlon L. Enriquez, MD
John A. Stern, MD
Konstantinos P. Lekkas, MD
p: 244-5109 f: 244-9066
A. John Glazier, MD
411 Laurel St., #2380, DM
Timothy M. Schurman, MD
Katrina A. Guest, MD
p: 288-8001 f: 288-5890
Lester J. Yen, MD
Gregory A. Hicklin, MD
5950 University Ave., #120, WDM
Linda C. McDanolds, ARNP
John H. Matsuura, MD
p: 875-9744 f: 875-9765
5950 University Ave., #131, WDM
John A. Stern, MD
p: 875-9550 f: 875-9551
1005 Pennsylvania Ave., #102-A,
Ottumwa
p: 641-684-2589
WDM = West Des Moines
Area code is 515 unless indicated
Source: http://www.iowaclinic.com/files/images/1/20100705170000.pdf
Dossier de presse 011210
PREMIERE JOURNEE NATIONALE DES MALADIES CARDIAQUES HEREDITAIRES DOSSIER DE PRESSE 1ERE JOURNEE NATIONALE DES MALADIES CARDIAQUES Plusieurs associations de malades, en collaboration avec le centre de Référence des Maladies Cardiaques Héréditaires, organisent une vaste journée d'information autour des maladies cardiaques héréditaires.
01-05.indd
Im Porträt: Der blaue Jude David Lasar • Martin Engelberg und Erwin Javor über Israel nach den Wahlen • Im Gespräch: Österreichs Israel-Botschafter Michael Rendi • Eric Frey über den Fall Madoff und die Folgen (1/2009) Nisan 5769 3,– www.nunu.at Jüdisches Handwerk in Wien: Neue Serie NU porträtiert jüdische Geschäftsleute wie etwa den Schuster David Malajev